Industry News
Pharmaceutical Industry News
Sunovion cashes in sublingual Parkinson’s drug, selling EU rights to Bial
Sunovion cashes in sublingual Parkinson's drug, selling EU rights to Bial ntaylor Tue, 09/07/2021 - 06:00
Teva’s pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug ntaylor Tue, 09/07/2021 - 05:56
Ivermectin Won’t Treat Covid-19, but Demand Is High Anyway
The drug has spared hundreds of millions of Africans from serious parasites, but clinical trials have repeatedly failed to show that it is effective against Covid. Still, U.S. demand is high.
Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganization
Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganization kdunleavy Fri, 09/03/2021 - 11:33
AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battle
AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battle nhigginsdunn Fri, 09/03/2021 - 11:17
CDC, FDA chiefs push back on White House COVID-19 booster plan: NYT
CDC, FDA chiefs push back on White House COVID-19 booster plan: NYT esagonowsky Fri, 09/03/2021 - 11:14
Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approval
Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approval bbulik Fri, 09/03/2021 - 10:34
With approval for China’s 2nd CAR-T therapy, Juno, WuXi joint venture goes up against Gilead and Fosun’s Yescarta
With approval for China's 2nd CAR-T therapy, Juno, WuXi joint venture goes up against Gilead and Fosun's Yescarta aliu Fri, 09/03/2021 - 10:00
Lilly’s COVID-19 antibody combo cleared for nationwide use as feds say it can tackle the dominant delta variant
Lilly's COVID-19 antibody combo cleared for nationwide use as feds say it can tackle the dominant delta variant esagonowsky Fri, 09/03/2021 - 09:43
Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing push
Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing push kdunleavy Fri, 09/03/2021 - 09:23
Fierce Pharma Asia—Sourcing Moderna’s COVID vaccine contaminant; Astellas’ gene therapy pause; Takeda’s cancer drug flop
Fierce Pharma Asia—Sourcing Moderna's COVID vaccine contaminant; Astellas' gene therapy pause; Takeda's cancer drug flop aliu Fri, 09/03/2021 - 07:51
First Biogen, now the FDA: Congressional Democrats request agency records about Aduhelm’s approval
First Biogen, now the FDA: Congressional Democrats request agency records about Aduhelm's approval nhigginsdunn Thu, 09/02/2021 - 14:28
Former Eli Lilly job applicants say the company’s hiring practices favor the young
Former Eli Lilly job applicants say the company's hiring practices favor the young esagonowsky Thu, 09/02/2021 - 13:55
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
After criticism, Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned
After criticism, Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned nhigginsdunn Thu, 09/02/2021 - 11:37
Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned
Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned nhigginsdunn Thu, 09/02/2021 - 11:37
America Desperately Needs a Much Better F.D.A.
The agency that regulates drug safety has become too cozy with the industry it's supposed to oversee.
Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC
Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC aliu Thu, 09/02/2021 - 10:46
Behind the rebrand: AMRI swaps acronym legacy name for Curia to set stage for future growth
Behind the rebrand: AMRI swaps acronym legacy name for Curia to set stage for future growth bbulik Thu, 09/02/2021 - 10:42
‘A bitter result’: Judge approves Purdue’s $4.5B opioid settlement that protects Sackler family from future lawsuits
'A bitter result': Judge approves Purdue's $4.5B opioid settlement that protects Sackler family from future lawsuits kdunleavy Thu, 09/02/2021 - 10:22